Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C

Related Experiment Video

Updated: Jul 5, 2026

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
06:55

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis

Published on: February 13, 2026

Urpo Nieminen1, Perttu E T Arkkila, Päivi Kärkkäinen

  • 1Department of Medicine, Division of Gastroenterology, Helsinki University Central Hospital, Helsinki, Finland.

Liver International : Official Journal of the International Association for the Study of the Liver
|May 17, 2008
PubMed

Insights

Hepatitis C virus (HCV) patients' age, BMI, and HCV duration predict liver fibrosis. Steatosis impacts fibrosis in GT-1, and inflammation in GT-3, suggesting biopsy scoring should include steatosis.

Area of Science:

  • Hepatology
  • Virology
  • Gastroenterology

Background:

  • The clinical utility of liver biopsy in managing hepatitis C virus (HCV) infection is debated.
  • Understanding factors influencing liver fibrosis progression is crucial for patient management.

Purpose of the Study:

  • To investigate the impact of clinical parameters, inflammation, and steatosis on liver fibrosis in HCV patients.
  • To identify independent risk factors for liver fibrosis in different HCV genotypes.

Main Methods:

  • Analysis of clinical data and liver histology from 510 HCV patients.
  • Assessment of hepatitis C virus genotypes, inflammation activity, steatosis, and fibrosis.
  • Statistical analysis to determine independent risk factors for fibrosis.

Main Results:

  • Hepatitis C virus genotypes 1, 2, and 3 were prevalent (38%, 15%, 45%).
  • Inflammation, fibrosis, and steatosis were observed in 68%, 19%, and 17% of biopsies, respectively.
  • Independent clinical predictors of fibrosis included age, BMI, and HCV duration. Histological factors varied by genotype: steatosis and inflammation were linked to fibrosis in GT-1, while only inflammation correlated with fibrosis in GT-3.

Conclusions:

  • Patient age, BMI, and HCV duration are independent risk factors for liver fibrosis.
  • Steatosis is a significant risk factor for fibrosis in HCV GT-1 patients.
  • Liver biopsy scoring for HCV should incorporate steatosis assessment alongside fibrosis and inflammation.
Abstract

More Related Videos

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):